Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Kirkpatrick

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Schizophrenia Research|July 24, 2014
Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophreniaPeter F Buckley, Brian J Miller, Anilkumar Pillai, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 19, 2004
The deficit syndrome in schizophrenia: implications for the treatment of negative symptomsCelso Arango, Robert W Buchanan, Brian Kirkpatrick, et al.
The Journal of Comparative Neurology|February 4, 2005
Ultrastructural localization of reelin in the cortex in post-mortem human brainRosalinda C Roberts, Leyan Xu, Joy K Roche, et al.
Psychiatry Research|February 5, 2008
Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese originXiang Wang, Shuqiao Yao, Brian Kirkpatrick, et al.
Schizophrenia Bulletin|November 17, 2012
Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary viewEmilio Fernandez-Egea, Clemente Garcia-Rizo, Jorge Zimbron, et al.
The Psychiatric Clinics of North America|August 28, 2007
Schizophrenia: measurements of psychopathologyJ P Lindenmayer, Philip D Harvey, Anzalee Khan, et al.
Schizophrenia Research|December 3, 2008
Differences in glucose tolerance between deficit and nondeficit schizophreniaBrian Kirkpatrick, Emilio Fernandez-Egea, Clemente Garcia-Rizo, et al.
The Journal of Nervous and Mental Disease|September 25, 2003
Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophreniaBrian Kirkpatrick, Nidia C Messias, Robert R Conley, et al.
Schizophrenia Research|November 23, 2007
Parental history of type 2 diabetes in patients with nonaffective psychosisEmilio Fernandez-Egea, Brian Miller, Miguel Bernardo, et al.
Schizophrenia Bulletin|December 13, 2018
Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus DomainsGregory P Strauss, Anthony O Ahmed, Jared W Young, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Schizophrenia Research|July 24, 2014
Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophreniaPeter F Buckley, Brian J Miller, Anilkumar Pillai, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 19, 2004
The deficit syndrome in schizophrenia: implications for the treatment of negative symptomsCelso Arango, Robert W Buchanan, Brian Kirkpatrick, et al.
The Journal of Comparative Neurology|February 4, 2005
Ultrastructural localization of reelin in the cortex in post-mortem human brainRosalinda C Roberts, Leyan Xu, Joy K Roche, et al.
Psychiatry Research|February 5, 2008
Psychopathology and neuropsychological impairments in deficit and nondeficit schizophrenia of Chinese originXiang Wang, Shuqiao Yao, Brian Kirkpatrick, et al.
Schizophrenia Bulletin|November 17, 2012
Diabetes or prediabetes in newly diagnosed patients with nonaffective psychosis? A historical and contemporary viewEmilio Fernandez-Egea, Clemente Garcia-Rizo, Jorge Zimbron, et al.
The Psychiatric Clinics of North America|August 28, 2007
Schizophrenia: measurements of psychopathologyJ P Lindenmayer, Philip D Harvey, Anzalee Khan, et al.
Schizophrenia Research|December 3, 2008
Differences in glucose tolerance between deficit and nondeficit schizophreniaBrian Kirkpatrick, Emilio Fernandez-Egea, Clemente Garcia-Rizo, et al.
The Journal of Nervous and Mental Disease|September 25, 2003
Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophreniaBrian Kirkpatrick, Nidia C Messias, Robert R Conley, et al.
Schizophrenia Research|November 23, 2007
Parental history of type 2 diabetes in patients with nonaffective psychosisEmilio Fernandez-Egea, Brian Miller, Miguel Bernardo, et al.
Schizophrenia Bulletin|December 13, 2018
Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus DomainsGregory P Strauss, Anthony O Ahmed, Jared W Young, et al.
Pageof 14